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ABSTRACT  The specific localization and the characterization of the parathyroid hormone (PTH) 
receptor  in  bone  have been  studied  using  18-d  embryonic  chick  calvariae  and  biologically 
active, electrolytically labeled  [1251] bovine PTH(I-34).  Binding was initiated by adding [12Sl]- 
bPTH(I-34) to bisected calvariae at 30°C. Steady state binding was achieved at 90 min at which 
time 10 mg dry wt of calvaria specifically bound 17% of the added [12Sl]bPTH  (I-34). Nonspecific 
binding in the  presence  of 244 nM  unlabeled  bPTH(1-34)  was <2%.  Insulin, glucagon,  and 
calcitonin (I/~g/ml) did not compete for PTH binding sites. Half-maximal  inhibition of binding 
was achieved at concentrations of unlabeled  bPTH(1-34)  or bPTH(I-84)  of about 10 nM. The 
range of concentration  (2-100  nM) over which bPTH(1-34)  and bPTH(I-84)  stimulated cyclic 
3'5'adenosine  monophosphate  (cAMP)  production  was  similar  to  that  which  inhibited  the 
binding of  [12Sl]bPTH(I-34).  Light microscope  autoradiograms showed that grains  were con- 
centrated  over cells  (osteoblasts  and progenitor cells)  at the external surface  of the calvariae 
and in trabeculae.  In the presence of excess unlabeled  PTH, labeling of control autoradiograms 
was reduced  to near background levels. No labeling of osteocytes or osteoclasts was observed. 
At  the  electron  microscopic  level,  grains  were  localized  primarily  over  cell  membranes.  A 
quantitative analysis  of grain  distribution  suggested  that cellular  internalization  of  PTH  oc- 
curred. 
Parathyroid  hormone (PTH) acts directly on bone acutely to 
increase bone resorption  and  decrease bone formation (1, 2) 
and  chronically  to  increase  both  bone  resorption  and  bone 
formation  (3).  These  actions  are  mediated  by  the  ceUular 
elements of bone by mechanisms involving, at least in part, the 
stimulation of cyclic Y,5' adenosine monophosphate (cAMP) 
production (4, 5). The evidence available indicates that PTH 
directly or indirectly influences all bone cells (osteogenic pre- 
cursors, osteoblasts, osteocytes, and osteoclasts) (6-9); however, 
recent reports  (10,  11) which  describe the  effect of PTH on 
cAMP  production  in  osteoblastlike  or osteoclastlike  cells  in 
monolayer culture implicate the osteoblast as the major osseous 
target cell of PTH. 
During the past five years, major advances in the production 
of  biologically  active,  high  specific-activity,  radioiodinated 
preparations of PTH have made it possible to investigate the 
previously  elusive  PTH  receptor  in  kidney  (12).  It  is  only 
recently that similar progress has been made in the identifica- 
tion  and  characterization  of PTH  receptors  in  bone:  using 
electrolytically  [L2SI]-labeled,  receptor-purified,  synthetic  bo- 
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vine PTH tetratriacontrapeptide  [bPTH(I-34)]  as ligand,  we 
demonstrated high affinity, specific hormone binding sites in 
mixed monolayer cultures of chick embryonic bone cells which 
correlated directly with PTH-stimulated cAMP production in 
the same cultures (13). 
The purpose of this investigation was to identify the bone 
cells in  the  frontal  bones  of chick embryonic calvariae  that 
bind bPTH(I-34)  in vitro and to determine  the biochemical 
characteristics  of  this  binding.  Light  microscope  autoradi- 
ograms of calvariae after exposure to [L25I]bPTH(1-34) showed 
predominant localization of grains over lining cells (osteoblasts 
and osteogenic precursor cells) and the cell processes of osteo- 
blasts undergoing transformation to osteocytes. Electron micro- 
scope  autoradiograms  showed  predominant  localization  of 
grains over cell membranes. A  quantitative  analysis of grain 
distribution  suggested  that significant  cellular internalization 
of PTH is a result of the receptor binding of this hormone to 
bone cells. 
The results of biochemical studies of the binding  of [x2sI]- 
bPTH(1-34) to calvariae in vitro showed rapid incorporation 
379 into calvariae which was competitively inhibited by unlabeled 
bPTH(1-34) and bPTH(1-84). The range of concentration over 
which  binding  was  inhibited  by unlabeled  bPTH(I-34)  was 
similar to that which stimulated cAMP production, suggesting 
a close relationship between these two events. 
MATERIALS  AND  METHODS 
Reagents 
We obtained Na~2~I  from New England Nuclear (Boston, MA), porcine insulin 
from Schwarz/Mann (Div. Becton, Dickinson & Co., Orangeburg, NY), glucagon 
(extracted from  porcine and  bovine  pancreas) and  phosphodiesterases from 
Sigma Chemical Co. (St. Louis, MO), [SNle,lSNle,~4Tyr] bovine PTH(3-34)amide 
(bPTH[3-34]amide) (14,  15) from Peninsula Laboratories, Inc. (San Carlos, CA). 
Synthetic human PTH(I-34) (synthesized according to the sequence of Brewer 
et al. [16]), (hPTH[1-34]B) and bovine PTH(I-34), (bPTH[I-34], 6000 U/rag) 
were donated by Beckman Bioproducts (Pain Alto, CA), salmon calcitonin (4500 
IU/mg)  by  Armour  Pharmaceutical  Company  (Kankakee,  IL),  and  bovine 
bPTH(1-84) (bPTH[ 1-84], 2500 U/rag) by Dr. Bryan Brewer (National Institutes 
of Health, Bethesda, MD). 
Embryonic Calvariae 
Fertilized chicken eggs (Feather Hill Farms, Petaluma, CA) were incubated 
at 37°C until day 18. Frontal bones of calvariae were then removed and dissected 
free of surrounding connective tissue (including periosteum). Isolated half cal- 
variae were washed (2 ml x 3) in Hanks' balanced salt solution (HBSS) containing 
20 mM  HEPES and equilibrated for  30 rain. at 30°C in 2  ml of incubation 
medium (MEM containing 20 mM HEPES and 0.1% BSA, fatty acid free, Miles 
Laboratories, Inc., Elkhart, IN). All experiments were performed after the 30- 
min equilibration period. 
Biochemical Binding Experiments 
Biologically  active, electrolytically  iodinated, receptor-purified [125I]bPTH(I- 
34) was prepared as previously described (12). For binding experiments, one-half 
calvaria was incubated in 0.5  ml of incubation medium at 30°C in a  shaking 
incubator. Binding was initiated by adding 12-32 ×  10  -3 nM [~25I]bPTH(1-34) 
(50--130 pg, specific activity 85-100/LCi//xg)  to the incubation medium containing 
an appropriate amount of unlabeled bPTH(1-34),  other peptide hormones, or 
diluent (10 mM acetic acid, 0.1% BSA), each in a volume of 10/(1. Incubations 
were terminated by washing the calvariae with iced (HBSS,  1 ml x  3 times). 
Each hall calvaria was then counted in a well-type gamma scintillation counter 
(efficiency 80%) to determine the radioactivity bound. Binding was expressed as 
the percent of the total radioactivity added to incubation media that was bound 
to calvariae. Total binding was that which occurred in the presence of diluent; 
nonspecific binding was that which occurred in the presence of244 nM unlabeled 
bPTH(I-34);  specific binding was  expressed as  the  total minus  nonspecific 
binding. Three types of binding experiments were performed: (a) the time course 
of the total and non-specific binding of labeled bPTH(I-34),  (b) the release of 
labeled bPTH(I-34)  bound;  labeled PTH  was incubated with calvariae until 
steady state binding was achieved, at which time 244 nM unlabeled PTH(I-34) 
was added  to the incubations, and binding was determined at various times 
thereafter, and (c) competitive binding assays; labeled bPTH(I-34) and various 
concentrations of either bPTH or other peptide hormones were added at the same 
time and  binding was  determined  after 90  min  of incubation.  The  peptide 
hormones tested were bPTH(I-34),  bPTH(I-84), hPTH(l-34), the PTH antag- 
onist, bPTH(3-34)amide, porcine insulin, salmon calcitonin, and porcine-bovine 
glucagon. 
Assay of cAMP 
Conditions used to measure cAMP accumulation were identical to those used 
in binding experiments except that the medium contained 1.0 mM 3 isobutyl-1- 
methyl xanthine (IBMX) (Sigma Chemical Co.).  Control experiments demon- 
strated that 1.0 mM IBMX did not interfere with PTH binding. PTH peptides 
were added to the incubation medium in 10 #1 of 10 mM acetic acid, 0.1% BSA, 
to give final concentrations ranging from 1.0-244 riM. After 15 min of incubation, 
hallcalvariae  were washed and transferred into 1 ml of N-propanol and sonicated 
three times tor  15 s after addition of (3H) cAMP (3000 cpm, 0.1  pmol) (New 
England Nuclear, Boston, MA) which was used as a  recovery standard.  Half 
calvariae were then removed from the sonicate and rinsed twice with 1 ml of N- 
propanol, and the washes were combined with the sonicate and centrifuged (15 
rain, 4,000 g). The supernatant was evaporated in a Brinkmarm sample concen- 
trator (Brinkmann Instruments, Inc., Westbury, NY). Samples were resuspended 
in 50 mM Na acetate, pH 4.0. Aliquots were assayed for (3H) cAMP (recovery, 
380  I-HE JOURNAL Of  CELL 81OLOGY • VOLUME 94,  1982 
70-90%),  and cAMP was measured using the competitive protein binding assay 
of Gilman (17) and expressed as pmol cAMP/10 mg dry wt of calvaria. Added 
phosphodicsterase (l mU/50/d sample) reduced cAMP extracted from calvariae 
to undetectable levels. The dose-response curves produced by multiple dilutions 
of samples were linear and parallel to the standard curve produced by authentic 
cAMP. 
The results (PTH binding, cAMP) are expressed per l0 mg dry wt of calvarlac. 
Haft calvaria weighed 7-9 nag and dry wl values correlated with DNA content 
(correlation coefficient r =  0.83). The mean DNA content of half calvariae was 
25-4O #g. 
Metabolism of PTH 
For rebinding studies, media recovered from incubations of [~2r'I]bPTH(1-34) 
with calvarlae at various times were incubated with freshly isolated calvariae for 
60 rain. Specific PTH binding to calvariae  was then determined. Similarly  derived 
medium was aLso chromatographer after 60-min incubations on BiG-Gel  P-6 80 
cm x  2 cm columns (Bio-Rad Laboratories, Richmond, CA) as described by 
Neuman et al. (18), except that 3 M acetic acid replaced formic acid in the 3-M 
guanidine elution buffer. Elution profiles of radioactivity  were compared to those 
obtained when media containing [lzSI]bPTH(I-34) which had been incubated 
without calvariae were chromatographed. 
Autoradiographic Studies 
Binding experiments for autoradiography were performed as described in the 
section entitled Biochemical Binding Experiments, except that ~ 1  0-15 times (120- 
555 ×  10  -3 nM) more [lz~I]bPTH(l-34) was added per hallcalvaria. After three 
washes with iced HBSS,  calvarlae were cut with a  razor blade into ~1  mm  2 
pieces. These pieces were immersion-fixed for 2 h at 4°C in 2.5% glutaraldehyde, 
0.7% paraformaldehyde in 0.2 M sodium bicarbonate buffer (S.B.  buffer). After 
an overnight wash at 4°C in 0.2  M  S.B.  buffer the tissue was osmicated in 
osmium tetroxide containing 1.5% KCN  for 2 h, rinsed in 0.2 M  S.B.  buffer, 
dehydrated in increasing concentrations of ethanol, and embedded in Epon-812. 
For light microscope autoradiography, l-b~n sections were placed on glass slides 
and coated with Kodak NTB-3 emuLsion, and developed after 2-6 wk exposure 
(19).  The light autoradiograms were used to determine the tissue blocks that 
contained sufficient radioactivity to perform electron microscope autoradiogra- 
phy. For electron microscope autoradiography, sections of 500 A were placed on 
parlodion-coated grids, overlaid with a  monolayer of Ilford-L-4 emulsion, ex- 
posed from 3-7 wk, developed, and stained with lead citrate (19, 20).  Electron 
autoradiograms were photographed in a Philips  300 microscope at a magnification 
of 12,000. 
Cell Internalization of Radioactivity 
Grain distribution in ceils observed in electron microscope autoradiograms 
was analyzed as described by Salpeter et al. (21)  as adapted by Goldfme et aL 
(20). In this method, the distance from the center of grains to the nearest plasma 
membrane is measured with a graphic data digitaLizer  (Ladd Research Industries, 
Burlington VT). Statistical evaluation of the data was performed by chi-square 
analysis (22). 
RESULTS 
Characteristics of Binding of 1251 bPTH(1-34) 
to Calvariae 
Binding  of [125I]bPTH(1-34)  to added  calvariae  increased 
with time to reach an apparent steady state after 60 rain.  10 nag 
dry wt of calvariae specifically  bound  17% of the total [x25I]- 
bPTH(I-34) at 90 min (Fig.  1). Binding was maintained at this 
level for at least  1 h. Nonspecific binding of [125I]bPTH(1-34) 
was <2%  of the total added labeled hormone added  at each 
time point. Addition of 244 nM unlabeled bPTH(1-34) after 
125  steady state binding of [  I]bPTH(1-34) had been established 
(90 rain) caused 50% of bound labeled hormone to be released 
from calvariae over a period of 60 min (Table I). 
Bovine  PTH(I-34)  and  bPTH(1-84)  were  equipotent  in 
competitively  inhibiting  the  binding  of [125I]bPTH(I-34)  to 
calvariae  (Fig.  2).  Half-maximal  inhibition  of binding  was 
achieved at concentrations of unlabeled hormone of about  I0 
nM.  The  competitive  antagonist  of  PTH  in  vitro, 
[aNle,iaNle,34Tyr]bPTH(3-34)amide,  [bPTH(3-34)amide],  was less effective  than bPTH(I-34)  and  bPTH(1-84)  in competi- 
tively inhibiting the binding of [125I]bPTH(1-34)  to calvariae; 
100  nM  bPTH(3-34)amide  was  required  for  half-maximal 
inhibition of binding.  The preparation of human PTH(I-34), 
synthesized according to the amino acid sequence proposed by 
Brewer et al. (16), (hPTH[1-34]B),  which has been found to be 
30- to 140-fold less potent than bPTH(1-34) in several bioassay 
systems (23, 24), was less effective in inhibiting the binding of 
[lzSI]bPTH(I-34), half-maximal inhibition occurring at -1,000 
riM. Salmon calcitonin, porcine-bovine glucagon, and porcine 
insulin were ineffective as inhibitors of [lz~I]bPTH(1-34) bind- 
ing to calvariae (Fig. 2). 
Stimulation of cAMP Production in Calvariae by 
PTH Peptides 
The time course for the stimulation of cAMP production in 
calvariae  by 0.244  and  12 nM PTH is shown in Fig.  3.  Peak 
responses were consistently observed at  15 min, and this time 
was selected to measure the responsivity of calvariae to various 
doses  of  PTH  and  other  peptides.  Bovine  PTH(I-34)  and 
bPTH(I-84)  were equipotent in this regard (Fig. 4). The range 
of concentrations (2-100  nM) over which bPTH(1-34)  stimu- 
lated  cAMP  in  calvaria  (Fig.  4)  was  similar  to  that  which 
inhibited  the  binding  of [1~I]PTH(I-34)  (Fig.  2).  As  in  the 
binding assay, hPTH(I-34)B  was considerably less potent than 
bPTH(1-34)  in the cAMP assay (Fig. 4). The PTH antagonist, 
bPTH(3-34)amide,  did not stimulate calvarial cAMP produc- 
tion but did inhibit this effect by bPTH(I-34).  The apparent 
inhibition  constant  of cAMP  production  (K~)  for  bPTH(3- 
34)amide  (73  nM),  when  a  single  near-maximal  dose  of 
bPTH(I-34)  was assayed in the presence of various doses of 
bPTH(3-34)amide,  was  -10  times  higher  than  the  apparent 
stimulation  constant  (K~)  for bPTH(1-34)  (data  not shown). 
This result is consistent with the difference in affinity noted in 
the inhibition of binding studies (Fig. 2). 
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FIGURE  1  Time course of [12SI]bPTH(1-34)  binding to calvariae at 
30°C.  Binding is expressed as percent of total radioactivity added 
per incubation bound to 10 mg dry wt of calvariae. Nonspecific and 
total binding are those that occurred in the presence and absence, 
respectively, of 244 nM unlabeled bPTH(I-34). Specific binding was 
calculated  by substracting  nonspecific from  total  binding at each 
time point. Results  are expressed as the mean value ±SD obtained 
in  two experiments in  which  triplicate determinations were done. 
17%  represents -2.30  fmol  bound.  (0)  Specific,  (O)  Non-specific 
binding. 
Metabolism of [~2S  l]bPTH(1-34) by Calvariae 
We  performed  experiments  of  two  types  which  strongly 
suggested that [12SI]bPTH(1-34) in the incubation medium was 
metabolized during incubation with calvariae.  The first were 
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FIGURE  2  Competitive inhibition  of  [~2Sl]bPTH(1-34)  binding  by 
peptide  hormones  at  30°C.  bPTH(1-34)  (O),  bPTH(1-84)  (IB), 
[eNle,~eNle34Tyr]bPTH(3_34)amide  (A),  hPTH(1-34),  Brewer  se- 
quence (O),  calcitonin  ([Z]), insulin  (V), and glucagon  (&).  Results 
are expressed as the mean values of three experiments performed 
in  triplicate  ±SD.  Nonspecific  binding  was  subtracted  from  all 
values.  Binding is expressed as % maximal binding;  100% binding 
represents  [1~Sl]bPTH(I-34)  binding  in  the  absence of  unlabeled 
bPTH(I-34)  (or 2.99 ±  0.47 fmoles). 
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FIGURE  3  Time course for stimulation of cAMP production in cal- 
variae by I  ng (0.244 nM)  (A) and 50 ng (12 nM)  (O)  bPTH(I-34) at 
30°C  in  the  presence  of  1  mM  IBMX.  cAMP  was  extracted  as 
described in Materials and Methods and assayed by the method of 
Gilman  (17). Basal levels (O) do not change with time. Data points 
are the mean values of duplicate determinations. 
TABLE  I 
Release of Labeled bPTH (1-34)  Bound to Calvariae 
bPTH  (1-34)  244 nM  0  15 min  30 min  60 min  90 min 
B/T*/10 mg dry weight calvariae  22.25:1: ±  1.64  21.52 ±  2.47  16.53 ±  0.76  10.52 ___ 0.22  10.21 :t: 0.83 
Labeled PTH was incubated with calvariae until steady state was achieved (90 min), at which time 244 nM unlabeled bPTH (I-34) was added to the incubations, 
and total binding was determined at times indicated. Results are the mean of one experiment in triplicate :t:SD. 
* B/T is the percent of the total radioactivity added to the incubation media that was bound to calvariae. 
:1:0.91 4- 0.01 fmol bound/10 mg dry weight calvariae. 
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[z25I]bPTH(1-34) for 30 rain at 30°C to calvariae, the specific 
binding of radioactivity to fresh calvariae was reduced by 50% 
compared  to  [~25I]bPTH(I-34) that  had  not  been  incubated 
with calvariae (Table II). Longer incubations of labeled hor- 
mone with calvariae further reduced specific binding of me- 
dium radioactivity to fresh calvariae. 
The second experiments were investigations of the radioac- 
tive  molecular  components  in  media  after  incubation  of 
[~I]bPTH(I-34) with calvariae.  After 60 min of incubation, 
the  major  portion  of medium  radioactivity  eluted  from gel 
filtration columns in a position consistent with a mol wt < 1,000 
(Fig.  5A).  Such degradation of medium [E25IIbPTH(I-34) by 
calvariae was markedly inhibited  by co-incubation of the la- 
beled hormone with excess unlabeled bPTH(I-34) (244 nM) 
although labeled fragments of PTH were observed even under 
these conditions (Fig. 5 B). 
Autoradiographic Studies 
Half calvariae were incubated for 60 rain with 1.5 x  105 cpm 
[~2~I]bPTH(I-34) alone (total binding) or with 244 nM unla- 
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FIGURE  4  Stimulation  of  cAMP  production  in  calvariae  by  PTH 
peptides at 30°C in the presence of 1 mM IBMX. cAMP was extracted 
as described in Materials and Methods. Results are expressed as the 
mean values ±SO obtained in two experiments in which triplicate 
determinations  were  done.  (C))bPTH(1-34),  (II)bPTH(1-84), 
(ZI) bPTH (3-34),  Amide Ana[ogue, (O) hPTH (1-34),  Brewer sequence. 
TABLE  II 
Rebinding Experiments 
% Specific binding after 60 rain of 
Duration of the first  incubation with freshly isolated 
incubation  calvariae 
min 
0  lOG 
30  50 ±  14.0 
60  32 ±  6.5 
90  20 ±  4.0 
Media  recovered  from  incubations  of  [1251]bPTH(1-34)  with  calvariae  at 
various  times  were  incubated  with  freshly  isolated  calvariae  for 60  rain  at 
30°C. Specific PTH binding to calvariae was then determined.  100% specific 
binding  (1.84  ~  0.10  fmol)  is  the  specific  binding  of  [1251]bPTH(1-34)  to 
calvariae after 60 min at 30°C without prior incubation of the labeled hormone 
with calvariae (mean ±  SE of two experiments in triplicate), 
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FIGURE  5  Gel filtration using BiG-Gel  P6 and acetic acid-guanidine 
buffer  (see Materials and Methods) of medium containing labeled 
bPTH(1-34) incubated for 60 rain at 30°C in the absence of calvariae 
(  .....  ,A and  B) and in the presence of calvariae without and with 
244 nM bPTH(1-34)  (  ,A and  B, respectively). Blue dextran was 
used  to  determine  the  void  volume,  and  riboflavin  was  used  to 
mark tool wt 375. 
beled  PTH  (nonspecific binding).  At the end  of incubation, 
total binding was 3.5  x  104 clam, (30%  of the added labeled 
hormone) and nonspecific binding was 2 x  103 cpm (1% of the 
added  labeled  hormone).  Light  microscope  autoradiograms 
representing total (Fig. 6 a and b) and nonspecific binding (Fig. 
6 c) are shown in the composite of Fig. 6. Autoradiograms were 
also processed after 10 rain of incubation, at which time  1.1 × 
104 cpm were bound. 
Few, if any, grains were observed on the micrographs rep- 
resenting nonspecific binding (Fig. 6 c). In micrographs repre- 
senting total binding, most of the grains were found associated 
with osteoblasts both in the peripheral portion of the calvariae 
(Fig. 6 a) and in trabeculae  (Fig. 6b) and to osteoprogenitor 
cells  on  the  peripheral  portion  of the  calvariae  (Fig.  6a). 
Osteoprogenitor ceils  were  characterized  by their  elongated 
shape, their localization on the outside portion of osteoblasts 
on the peripheral portion of the calvariae, and the absence of 
a well-developed rough endoplasmic reticulum on the electron 
microscope pictures. Grains were also seen overlying uncalci- 
fled collagen. At the electron microscopic level, the grains seen 
overlying this osteid tissue were predominantly associated with 
cellular cytoplasmic processes originating from osteoblasts sur- 
rounded by uncalcified matrix (Fig. 6 e). We did not observe 
labeling of osteoclasts after either  10 min or 60 rain of incu- 
bation at the PTH concentrations used (Fig. 6 d).  It is to be 
noted that the mononuclear cells that are in this micrograph in 
the immediate vicinity of the osteoclasts are not labeled. How- 
ever, in other micrographs, labeling of osteoblasts positioned 
on the surface of the bone behind apparently active osteoclasts 
was present. 
Electron  microscope  autoradiography  demonstrated  that FIGURE 6  Micrographs  of binding of [12Sl]bPTH(1-34) to calvariae after 60 min of incubation at 30°C. (a,  b)  Light microscope 
autoradiograms of total [12Sl]bPTH(1-34) binding to cells (osteoblasts and osteoprogenitor  cells) at the peripheral portion of the 
calvariae (a)  and  to osteoblasts located  inside of trabeculae  (b)  (x 450). (c)  Light  microscope  autoradiogram of nonspecific 
[t2Sl]bPTH(1-34) binding to trabeculae after 60 rain. No grains are observed when 244 nM bPTH(1-34) is added together with the 
labeled PTH  (x 450). (d)  Light  microscope  autoradiogram of  [~Sl]bPTH(1-34)  binding to calvariae after 60 rain,  showing the 
absence of grain  association with  osteoclasts (x 450). (e)  Electron  microscope  autoradiogram of  [~2Sl]bPTH(1-34) binding to 
calvariae after 60 min, showing that the grains seen  overlying collagen at the light microscopic level (b) are associated with plasma 
membranes (X 34,000). 
after  60  min  of incubation  the  grains  were  predominantly  performed a  quantitative  analysis of the grains overlying the 
associated with the plasma membrane of osteoblasts (Fig. 7 a).  cell. The expected distribution  of grains overlying the ceils, if 
Grains were also observed over coated pits (Fig. 7 b) and coated  all the radioactivity arose solely from 1~5I bound to the plasma 
vesicles (Fig. 7 c). To determine whether grain distribution was  membrane, is shown in Fig. 8 A. One would expect 60% of the 
consistent with the cellular internalization of radioactivity, we  grains to be within 0.1/~m of the plasma membrane, while only 
SItvE [r At.  Parathyroid Hormone Receptor in Intact Embryonic Chick Bone  383 FIC;URE  7  Electron microscope autoradiogram of [1251]bPTH(1-34)  total binding to calvariae after 60 min of incubation at 30°C 
(x 34,000). (a) Association of grains with plasma membrane of osteoblasts (OB).  (b,  c) Association of grains with a coated pit (b) 
and a coated vesicle (c). Background was <5%. (co), coated pit; (cv)  coated vesicle. 
2% would be beyond 1 #m. The actual distribution of grains at 
a given distance from the plasma membrane found in our study 
is shown in Fig.  8 B. Only 30% of the grains were within 0.1 
/~m from the plasma membrane.  Chi-square analysis of these 
data is consistent with significant internalization of radioactiv- 
ity by osteoblasts (P <  0.001). 
DISCUSSION 
The present investigation was performed using intact calvariae, 
rather  than  isolated  cultured  bone  cells,  so  as  to  observe 
[126I]bPTH(I-34) binding to a full complement of the cellular 
elements of bone in their natural  environment.  Light micro- 
scope autoradiograms showed a  surprisingly well-defined lo- 
calization  of radioactivity  over  osteoprogenitor  cells,  osteo- 
blasts  and  the cell processes of osteoblasts  in  the  process of 
being  transformed  into  osteocytes.  Nonspecific binding  was 
minimal. In contrast, we did not observe localization of radio- 
activity over osteocytes or osteoclasts. Although it is likely that 
these latter cells do not bind PTH, several alternative  expla- 
nations are possible:  (a) we used embryonic bone,  and PTH 
receptors may only appear on osteoclasts and osteocytes after 
the embryo hatches; (b) our chances of observing localization 
of radioactivity over osteoclasts  were diminished  because  of 
the paucity of these cells in chick calvariae; (c) the labeling of 
osteoclasts and osteocytes may have been precluded by poor 
penetration of incubation medium into calvariae; and (d) the 
affinity of PTH receptors on osteoclasts and osteocytes may be 
lower than that of those on osteoblasts so that, at the concen- 
trations of [125I]bPTH(I-34) used, labeling of these ceils could 
not be detected. 
After 60 min of incubation, most of the grains observed on 
electron microscopic autoradiograms were associated with the 
plasma membranes of osteoblastlike ceils,  consistent with the 
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FIGURE  8  Grain distribution profiles for a line source of [1251] (A) 
(289  grains  counted)  and  for  [1251]bPTH(1-34)  grains  from  the 
plasma membrane (B) (658 grains counted, 300 micrographs). Anal- 
ysis of the grain distribution was performed following the method 
described by Salpeter et al.  (21) (see Materials and  Methods).  (A) 
Distance between grains and a line source.  (B)  Distance between 
grains and plasma membrane. 
presumed  action  of PTH  via  a  membrane-bound  receptor. 
However, quantitative analysis of the grain distribution over- 
lying cells  indicated  that  internalization  of radioactivity oc- 
curred.  Our  data  do  not  permit  the  conclusion  that  this 
"internalized"  radioactivity was derived  originally from that 
intact PTH bound to plasma membranes, but several ancillary 
observations suggest that this may be the case. Specifically, we 
observed grains associated with coated pits and vesicles,  struc- 
tures known in other systems (25, 26) to be involved in ligand- 
receptor complex internalization.  Moreover, it is known, from 
studies  on  liver,  that  ~2~I cannot  be  fLxed during  autoradi- 
ographic processing (27).  Thus,  it  is  likely that  internalized 
radioactivity in our studies represents  [125I]-bPTH(1-34)  or a 
labeled fragment of this peptide that is being processed by the 
cell  subsequent  to membrane-associated  receptor binding of 
the intact peptide. In contrast to the studies performed in renal 
tissue by Nordquist et al.  (28)  using chloramine T  iodinated 
PTH  which  was  probably  biologically inactive,  we  did  not 
identify  a  predominant  localization  of  biologically  active 
[12sI]PTH in mitochondria. 
On the basis of our autoradiographic studies, it is reasonabi 
to  assume  that  osteoblastlike  cells  accounted  for the  majol 
portion of the specific binding of [12SI]bPTH(1-34) we observed 
in calvariae  incubated  with this  ligand.  This binding was of 
high aft'mity; half-maximal inhibition of binding was achieved 
at  a  concentration  of  10  nM  unlabeled  bPTH(1-34).  This 
apparent affinity is similar to that found in chicken (12), dog 
(29), and human (29) renal plasma membranes but lower than 
that  in  isolated  bone  cells  in  culture  (13).  However,  firm 
conclusions about the number of receptor types present on cells 
binding PTH in chick calvariae and the dissociation constant(s) 
of PTH from its receptor(s) cannot be drawn from these studies 
because the labeled PTH ligand we used was both internalized 
by cells and metabolized in the medium, and the ligand or a 
component thereof was irreversibly bound, as suggested by the 
acute  displacement  of only  50%  of [12SI]bPTH(1-34)  bound 
after  90  min  of incubation  with  calvariae  by added  excess 
unlabeled bPTH(l-34). 
These considerations aside, several of our observations sug- 
gest that the  [t25I]bPTH(1-34) bound to calvariae  represents 
biologically active hormone associated with a specific receptor: 
(a) the binding of [~25I]bPTH(1-34)  was highly specific (only 
unlabeled PTH but not other peptide hormones competitively 
inhibited binding); (b) there was close correspondence between 
the  ability  of various  PTH peptides  to competitively inhibit 
binding and stimulate cAMP production; and (c) the products 
of the metabolism of [~25I]bPTH(1-34)  by calvariae bound less 
well to fresh calvariae than [~25I]bPTH(1-34). 
We found that bPTH(I-34) and bPTH(I-84) were equipo- 
tent in competitively inhibiting the binding of [~25I]bPTH(I- 
34) and in stimulating cAMP production. Although this obser- 
vation does not support the recent suggestion of Martin et al. 
(30),  based on whole canine bone perfusion studies,  that  an 
amino-region fragment of PTH and not PTH(1-84) has osseous 
activity, it is possible that the binding and adenylate cyclase 
activity of bPTH(I-84) in our system was due to a biologically 
active fragment of the hormone produced by the metabolism 
of PTH(1-84) by calvariae. 
In agreement with  our previous investigations  of isolated 
renal  tubules  (31),  renal  plasma  membranes  from the avian 
(12),  canine  (29)  human (29),  and avian cultured  bone cells 
(13), we observed that the range of concentrations over which 
unlabeled  bPTH(I-34)  competitively  inhibited  binding  of 
[~2sI]bPTH(1-34)  in embryonic avian calvariae corresponded 
closely with that which stimulated cAMP production. Although 
such correspondence may be coincidental,  the uniformity of 
the  finding  strongly suggests  that  it  is  representative  of the 
quantitative relationship between these two events under phys- 
iologic conditions. As expected, the peptide [gNle,~SNle,34Tyr]- 
bPTH(3-34)amide,  a known competitive inhibitor of PTH in 
vitro (14,  15), was found to competitively inhibit the binding 
of [~2SI]bPTH(I-34),  to inhibit the stimulation of cAMP pro- 
duction, and to have no stimulatory effect on cAMP production 
in calvaria¢. These observations provide further  evidence in 
favor of the specificity of the PTH binding we have observed. 
The present  investigation  represents  the initiation  of what 
appears to be an extremely fertile ground for the study of the 
structure-function  relationships  of PTH  hormone  action  in 
general and of the initial events in PTH action on bone cells in 
particular. In the future, it is important that the relative abilities 
of cultured isolated and functionally different bone cell popu- 
lations  to bind  PTH  be  thoroughly investigated  so that  our 
observations,  with respect  to whole calvariae,  that the osteo- 
blastlike cell is the major direct osseous target of PTH can be 
buttressed  or refuted. On the other hand,  further exploration 
of the calvarial system described in this work will be helpful in 
approaching questions which can be better answered by using 
intact bone. 
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